Sinovac Biotech Ltd (SVA) stock
SVANasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.47+0.00 (0.00%)
Close on Nov 13, 2026Market cap $464.94MP/E –Yield 850.08%
Sinovac Biotech cash
Cash and short-term investments held at the end of each period.
Sinovac Biotech's cash was $5.97B at Dec 31, 2025. For fiscal 2025 it was $5.97B, down 40.0% from the year before. Over ten years it grew 57.0% a year on average. The highest annual figure on record is $13.42B in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.97B | -40.0% |
| FY2024 | Dec 31, 2024 | $9.95B | -9.8% |
| FY2023 | Dec 31, 2023 | $11.02B | +4.6% |
| FY2022 | Dec 31, 2022 | $10.54B | -21.4% |
| FY2021 | Dec 31, 2021 | $13.42B | +1031.7% |
| FY2020 | Dec 31, 2020 | $1.19B | +475.0% |
| FY2019 | Dec 31, 2019 | $206.15M | +16.4% |
| FY2018 | Dec 31, 2018 | $177.08M | +52.7% |
| FY2017 | Dec 31, 2017 | $115.96M | +77.2% |
| FY2016 | Dec 31, 2016 | $65.44M | -0.0% |
| FY2015 | Dec 31, 2015 | $65.46M | -27.1% |
| FY2014 | Dec 31, 2014 | $89.79M | -15.7% |
| FY2013 | Dec 31, 2013 | $106.52M | +16.8% |
| FY2012 | Dec 31, 2012 | $91.22M | -12.5% |
| FY2011 | Dec 31, 2011 | $104.29M | +1.2% |
| FY2010 | Dec 31, 2010 | $103.10M | +37.5% |
| FY2009 | Dec 31, 2009 | $74.95M | +127.9% |
| FY2008 | Dec 31, 2008 | $32.89M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $5.97B | -55.5% |
| Q4 FY2024 | Dec 31, 2024 | $9.95B | +739.2% |
| Q4 FY2023 | Dec 31, 2023 | $11.02B | +5247.4% |
| Q4 FY2022 | Dec 31, 2022 | $10.54B | +5852.5% |
| Q4 FY2021 | Dec 31, 2021 | $13.42B | +11468.5% |
| Q4 FY2020 | Dec 31, 2020 | $1.19B | +1711.5% |
| Q4 FY2019 | Dec 31, 2019 | $206.15M | +214.9% |
| Q4 FY2018 | Dec 31, 2018 | $177.08M | +97.2% |
| Q4 FY2017 | Dec 31, 2017 | $115.96M | +8.9% |
| Q4 FY2016 | Dec 31, 2016 | $65.44M | -28.3% |
| Q4 FY2015 | Dec 31, 2015 | $65.46M | -37.2% |
| Q4 FY2014 | Dec 31, 2014 | $89.79M | -12.9% |
| Q4 FY2013 | Dec 31, 2013 | $106.52M | +42.1% |
| Q4 FY2012 | Dec 31, 2012 | $91.22M | +177.3% |
| Q4 FY2011 | Dec 31, 2011 | $104.29M | – |
| Q4 FY2010 | Dec 31, 2010 | $103.10M | – |
| Q4 FY2009 | Dec 31, 2009 | $74.95M | – |
| Q4 FY2008 | Dec 31, 2008 | $32.89M | – |
See a number that looks wrong?